Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 12953084

A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Natl Cancer Inst
Publication date
2003 Sep 3
First author
Dearnaley DP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2003 Sep 3;95(17):1262-3. doi: 10.1093/jnci/djg062.
    note
    Source null
    related pmid
    12953073
    relationship
    Comment in
  2. citation
    J Natl Cancer Inst. 2003 Sep 3;95(17):1273-4. doi: 10.1093/jnci/95.17.1273.
    note
    Source null
    related pmid
    12953081
    relationship
    Comment in

Authors and identifiers

  1. name
    Dearnaley DP
    type
    Author
  2. name
    Sydes MR
    type
    Author
  3. name
    Mason MD
    type
    Author
  4. name
    Stott M
    type
    Author
  5. name
    Powell CS
    type
    Author
  6. name
    Robinson AC
    type
    Author
  7. name
    Thompson PM
    type
    Author
  8. name
    Moffat LE
    type
    Author
  9. name
    Naylor SL
    type
    Author
  10. name
    Parmar MK
    type
    Author
  11. name
    Mrc Pr05 Collaborators
    type
    CollectiveName
Complete bibliographic record and source provenance
authors
  1. name
    Dearnaley DP
    type
    Author
  2. name
    Sydes MR
    type
    Author
  3. name
    Mason MD
    type
    Author
  4. name
    Stott M
    type
    Author
  5. name
    Powell CS
    type
    Author
  6. name
    Robinson AC
    type
    Author
  7. name
    Thompson PM
    type
    Author
  8. name
    Moffat LE
    type
    Author
  9. name
    Naylor SL
    type
    Author
  10. name
    Parmar MK
    type
    Author
  11. name
    Mrc Pr05 Collaborators
    type
    CollectiveName
bibliography ids
  1. nci-bib-2374f8ac0519f2f9ae93730b
book metadata
content sha256
b5887f6633c8606bc5641ef648be8b82e4ee359799e2923dbc1f76e36dbe8d73
document type
citation
dois
  1. 10.1093/jnci/djg038
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:12953084
immutable id
pubmed:12953084@b5887f6633c8606bc5641ef648be8b82e4ee359799e2923dbc1f76e36dbe8d73
journal
abbreviation
J Natl Cancer Inst
issn electronic
1460-2105
issn print
0027-8874
issue
17
name
Journal of the National Cancer Institute
nlm unique id
7503089
pages
1300-11
volume
95
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Natl Cancer Inst. 2003 Sep 3;95(17):1262-3. doi: 10.1093/jnci/djg062.
    note
    Source null
    related pmid
    12953073
    relationship
    Comment in
  2. citation
    J Natl Cancer Inst. 2003 Sep 3;95(17):1273-4. doi: 10.1093/jnci/95.17.1273.
    note
    Source null
    related pmid
    12953081
    relationship
    Comment in
outcomes validated
false
pmid
12953084
provenance
batch id
2d0158fe73b50bb1a4bf
provider
NCBI PubMed ESummary
record sha256
c977e8518b28ad640c97d530c7e347ce3267dbfeff16c86c4818f03a3cb11775
response sha256
d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
retrieved at
2026-09-09T23:45:50.935339+00:00
publication date
display
2003 Sep 3
precision
day
year
2003
publication types
  1. Clinical Trial
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/12953084/
title
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial).

Preserved source evidence · Not medical advice